Advancing innovation in accelerated cancer diagnosis

Innovate UK, on behalf of the Office for Life Sciences’ (OLS) Cancer Healthcare Goals programme, will invest up to £25.4 million, to support the clinical validation and evaluation of early cancer diagnostic technologies and devices. Location: National Funding organisation: Innovate UK, on behalf of the Office for Life Sciences’ (OLS) Who can apply: Public Sector, Non-profit, Private Sector How much you can get: From £1.5 million to £4 million Total size of grant scheme: £25.4 million Opening date: 1 September 2026, 10:00am Closing date: 28 October 2026, 11:00am